| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/08/2005 | US20050197302 Organic amine salt of closantel; administered with carrier and optionally macrocyclic lactone; bioavailability, blood concentration; veterinary medicine |
| 09/08/2005 | US20050196512 Structured lipid containing compositions and methods with health and nutrition promoting characteristics |
| 09/08/2005 | US20050196470 Method and composition for enhancing sexual desire |
| 09/08/2005 | US20050196459 Carvedilol salts, anhydrates and/or solvate thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods |
| 09/08/2005 | US20050196458 Odor absorbing pad for shoes |
| 09/08/2005 | US20050196457 Controlling particle size distribution; preparing a quench liquid;pumping the first phase and the second phase through manifold that includes a plurality of static mixers to form an emulsion; polydispersity |
| 09/08/2005 | US20050196456 Controlled release particles |
| 09/08/2005 | US20050196455 Pellet comprises at least one agent and at least one disintegrant of sodium starch glycolate or croscarmellose sodium, and an aqueous medium for administering to patient; localized; pyrogen-free; drug delivery; kits |
| 09/08/2005 | US20050196454 Poly(styrene-b-4-vinylphenoxyphthalonitrile) complexed with cobalt or other Group VIII metals; protective coatings |
| 09/08/2005 | US20050196453 Crystal particles of escitalopram oxalate with a broad particle size suitable for use in direct compression; prior to crystallization comprising at least 0.01% (w/w) of or E- Z-4-(4-dimethylamino--dimethylamino-1-(4-fluorophenyl)-but-1-enyl)-3-hydroxymethyl-benzonitrile; tablets |
| 09/08/2005 | US20050196452 Surface directed cellular attachment |
| 09/08/2005 | US20050196451 Tolperisone-containing pharmaceutical preparation with controllable active-substance release for oral administration |
| 09/08/2005 | US20050196450 Administering ethyl and/or isopropyl alcohol to burns and surrounding tissues; may contain ammonium hydroxide and/or bicarbonate; reducing level of cytokine, interleukin, and/or tumor necrosis factor; wound healing agents |
| 09/08/2005 | US20050196449 Embolization |
| 09/08/2005 | US20050196448 Polymeric compositions and dosage forms comprising the same |
| 09/08/2005 | US20050196447 Shell semipermeable to liquid medium comprised of a water insoluble film forming polymer and a gelling agent; second shell different than the firstin contact with core exterior surface; drug delivery of one or more active ingredients in a controlled or delayed release |
| 09/08/2005 | US20050196446 Polymeric compositions and dosage forms comprising the same |
| 09/08/2005 | US20050196445 Edible microcrystalline cellulose and carrageenan coating composition |
| 09/08/2005 | US20050196444 Aqueous polymer dispersions based on alkyl (meth)acrylates |
| 09/08/2005 | US20050196443 Pulsatile release compositions and methods for enhanced intestinal drug absorption |
| 09/08/2005 | US20050196442 Water insoluble, film forming polymer of cellulose esters and/or ethers, polyvinyl alcohol, polyvinyl acetate, polycaprolactone, poly(meth)acrylate, poly(meth)acrylic acid or copolymers ;gelling agent; and a multisolvent system including water and miscible solvent; core and semipermeable shell |
| 09/08/2005 | US20050196441 Polymer carrier soluble in a solvent and drug such as nicotine, morphine, vitamins, antiseptics, antiinflammatory agents, antibiotics, anticarcinogenic agents, enzymes, proteins, vaccines; veterinary medicine; formed by electrohydrodynamic spraying; high speed disintegration |
| 09/08/2005 | US20050196440 Mucoadhesive drug delivery devices and methods of making and using thereof |
| 09/08/2005 | US20050196439 Process for co-spray drying agents with dry silicified MCC |
| 09/08/2005 | US20050196438 Fast dissolving tablet and method of preparing the same |
| 09/08/2005 | US20050196437 Hard capsules |
| 09/08/2005 | US20050196436 Blends of different acyl gellan gums and starch |
| 09/08/2005 | US20050196435 Encapsulating drug; drug delivery |
| 09/08/2005 | US20050196434 Pharmaceutical composition and method for the transdermal delivery of magnesium |
| 09/08/2005 | US20050196433 Delivery mechanism for magnesium which alleviates the disadvantages associated with the oral administration of magnesium supplements; magnesium chloride, zinc chloride, pluronic lecithin organogel, vitamin B6; diabetes, hypertension, high cholesterol, cardiac arrhythmias, acute myocardial infarction |
| 09/08/2005 | US20050196428 Dilute aqueous solution containing epidermal growth factor in gel |
| 09/08/2005 | US20050196427 Engineered proteins, and methods of making and using |
| 09/08/2005 | US20050196426 A polymeric hydrogel material that permits cellular ingrowth and has controlled rate of expansion optimized for delivery through microcatheter or catheter without need for a nonaqueous solvent or coating |
| 09/08/2005 | US20050196424 Medical devices and methods for producing the same |
| 09/08/2005 | US20050196421 Preventing surgical adhesions, by delivering a tissue-reactive polymer, then a fibrosis-inhibiting agent to the coated tissue |
| 09/08/2005 | US20050196417 Taste masking complex of antihistamine and alginate |
| 09/08/2005 | US20050196416 Dispersions prepared by use of self-stabilizing agents |
| 09/08/2005 | US20050196399 antibody capable of specifically recognizing two regions of the A4 peptide/A beta 4, wherein the first region comprises the amino acid sequence AEFRHDSGY and the second region comprises the amino acid sequence YEVHHQKLVFFAEDVG |
| 09/08/2005 | US20050196383 Novel adjuvant system reduces risk of toxic side effects; based on honey bee venom melittin; oligonucleotide complexed or covalently linked with immunostimulatory peptide; non toxic DNA and RNA sequences to stimulate reactions against specific antigens, without risk of systemic immunogenicity, toxicity |
| 09/08/2005 | US20050196374 Defecation deodorant |
| 09/08/2005 | US20050196370 Antimicrobial contact lens disinfecting and rewetting solutions; self emulsifying |
| 09/08/2005 | US20050196365 Method for improving sensory characteristics of semisolid predominantly anhydrous lipids |
| 09/08/2005 | US20050196358 Film products having controlled disintegration properties |
| 09/08/2005 | US20050196357 Film products having controlled disintegration properties |
| 09/08/2005 | US20050196355 Film products having controlled disintegration properties |
| 09/08/2005 | US20050196353 Nonaqueous dentifrices containing hydroxypropyl cellulose combined with concentrated glycerol, diglycerol, propylene glycol, 1,3-butylene glycol and/or polyethylene glycols; stability, shape retention |
| 09/08/2005 | US20050196350 Stabilized peroxide compositions |
| 09/08/2005 | US20050196349 Compositions and methods for bone formation and remodeling |
| 09/08/2005 | US20050196348 Stabilized peroxide compositions |
| 09/08/2005 | US20050196347 Low viscosity, high oil in water sunscreen formulations; small amount of 1,2-fattyglycol additive |
| 09/08/2005 | US20050196346 Micronized or spray dried solid active ingredient (oxitropium or tiotropium salts which are soluble in water), and coating consisting of fatty acid, alcohol derivative, and poloxamer |
| 09/08/2005 | US20050196345 Compressed air inhaler for pulmonary application of liposomal powder aerosols and powder aerosols |
| 09/08/2005 | US20050195943 Method of forming subtraction images |
| 09/08/2005 | US20050194303 MEMS flow module with filtration and pressure regulation capabilities |
| 09/08/2005 | DE60110057T2 Liposomen enthaltend eine eingeschlossene verbindung in übersattigter lösung Liposomes containing an entrapped compound in solution übersattigter |
| 09/08/2005 | DE102004009051A1 Microcapsule immobilizing species for use in chemistry, food- or pharmaceutical technologies is stable when stored in concentrated medium and is ruptured on slight stressing following dilution |
| 09/08/2005 | DE102004008804A1 Mehrschichttablette Multilayer tablet |
| 09/08/2005 | DE102004008020A1 Preparing enzyme granules, useful in nutritional, cleaning and pharmaceutical compositions, by spraying enzyme solution into gas stream containing solid particles, followed by drying and granulation |
| 09/07/2005 | EP1571213A1 Bifidobacterium longum AR81 (KCCM-10492) enabling inhibition of rotavirus and active protein separated therefrom |
| 09/07/2005 | EP1571164A2 Aqueous polymer dispersions based on alkyl (meth)acrylates |
| 09/07/2005 | EP1570861A2 Pharmaceutical compositions based on anticholinergically effective compounds and beta-mimetics |
| 09/07/2005 | EP1570850A1 Topical formulations for treatment of rosacea |
| 09/07/2005 | EP1570849A1 Freeze-dried preparation of stabilized anthracycline compound |
| 09/07/2005 | EP1570848A1 Treating postmenopausal women using ultra-low doses of estrogen |
| 09/07/2005 | EP1570843A1 Blends of different acyl gellan gums and starch |
| 09/07/2005 | EP1570842A2 Composition containing chondroitin sulphate |
| 09/07/2005 | EP1570840A2 Topical composition comprising n-acetylaldosamines or n-acetylamino acids |
| 09/07/2005 | EP1570823A2 Substained analgesia achieved with buprenorphine |
| 09/07/2005 | EP1569724A1 Formulations containing melatonin, ginkgo biloba, and biotin |
| 09/07/2005 | EP1569693A1 Pharmaceutical compositions having a modified vehicle |
| 09/07/2005 | EP1569692A2 Betaine and salicylic acid compositions |
| 09/07/2005 | EP1569689A2 Combination il2/anti-her2-antibody therapy for cancers characterized by overexpression of the her2 receptor protein |
| 09/07/2005 | EP1569681A1 Freeze-dried interferon-gammad; composition for transpulmonary administration and inhalation system therefor |
| 09/07/2005 | EP1569677A1 Liposomal composition comprising haptotactic peptides |
| 09/07/2005 | EP1569673A1 Novel exendin agonist formulations and methods of administration thereof |
| 09/07/2005 | EP1569664A2 Bioerodible poly(ortho esters) from dioxane-based di(ketene acetals), and block copolymers containing them |
| 09/07/2005 | EP1569663A2 Ifosfamide compositions for parenteral administration and a process for their preparation |
| 09/07/2005 | EP1569662A2 Treatment of neurodegenerative disease through intracranial delivery of short interfering rna (sirna) |
| 09/07/2005 | EP1569657A1 Use of amphiphilic lipids for the preparation of a pharmaceutical composition for reducing tumor metastasis |
| 09/07/2005 | EP1569651A1 Tablet comprising efletirizine and pseudoephedrine |
| 09/07/2005 | EP1569648A1 Prodrugs for use a ophthalmic agents |
| 09/07/2005 | EP1569629A1 Topical antiinflammatory preparations of g(g)-terpinene |
| 09/07/2005 | EP1569626A1 Pharmaceutical porous particles |
| 09/07/2005 | EP1569625A1 Solid mucoadhesive composition |
| 09/07/2005 | EP1569624A2 Density-controlled particulate suspensions for foodstuff, cosmetic, pharmaceutical and other uses |
| 09/07/2005 | EP1569623A1 A topical nanoparticulate spironolactone formulation |
| 09/07/2005 | EP1569622A1 Mannose-based fast dissolving tablets |
| 09/07/2005 | EP1569621A1 Microparticles prepared using an ionic liquid |
| 09/07/2005 | EP1569620A1 Nanoparticulate bioactive agents |
| 09/07/2005 | EP1569619A1 Ph triggered targeted controlled release systems |
| 09/07/2005 | EP1569618A2 Methods and compositions for applying pharmacologic agents to the ear |
| 09/07/2005 | EP1569617A1 Water stabilized medicinal aerosol formulation related applications |
| 09/07/2005 | EP1569616A2 An exopolysaccharides delivery system for active molecules |
| 09/07/2005 | EP1569596A1 A method for preparing a medical solution for the manufacture of a medicament for peritoneal dialysis |
| 09/07/2005 | EP1469824B1 Pharmaceutical composition for extended/sustained release of therapeutically active ingredient |
| 09/07/2005 | EP1455760B1 Ultrapure oral fludara formulation with a fast releasing active substance |
| 09/07/2005 | EP1447094A9 Remedies for pruritus |
| 09/07/2005 | EP1439829B1 Pharmaceutical containing 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol and providing delayed release of the active ingredient |
| 09/07/2005 | EP1379223A4 Dental formulation |
| 09/07/2005 | EP1368062B1 Gel for the treatment of cats and dogs |